Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1995-06-07
1998-01-20
Jones, W. Gary
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 912, 435 71, 435 79, 536 231, 536 243, 536 2433, 5303881, 530300, 530350, C12Q 168, C12P 1934, C07H 2102, C07H 2104
Patent
active
057100012
ABSTRACT:
The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human breast and ovarian cancer predisposing gene (BRCA1), some mutant alleles of which cause susceptibility to cancer, in particular breast and ovarian cancer. More specifically, the invention relates to germline mutations in the BRCA1 gene and their use in the diagnosis of predisposition to breast and ovarian cancer. The present invention further relates to somatic mutations in the BRCA1 gene in human breast and ovarian cancer and their use in the diagnosis and prognosis of human breast and ovarian cancer. Additionally, the invention relates to somatic mutations in the BRCA1 gene in other human cancers and their use in the diagnosis and prognosis of human cancers. The invention also relates to the therapy of human cancers which have a mutation in the BRCA1 gene, including gene therapy, protein replacement therapy and protein mimetics. The invention further relates to the screening of drugs for cancer therapy. Finally, the invention relates to the screening of the BRCA1 gene for mutations, which are useful for diagnosing the predisposition to breast and ovarian cancer.
REFERENCES:
patent: 5236844 (1993-08-01), Basset et al.
Albertsen, H., et al. (1994). "Genetic Mapping of the BRCA1 Region on Chromosome 17q21," Am. J. Hum. Genet. 54:516-525.
Anderson, D.E. (1972). "A Genetic Study of Human Breast Cancer," J. Natl. Cancer Inst. 48:1029-1034.
Arason, A., et al. (1993). "Linkage Analysis of Chromosome 17q Markers and Breast-Ovarian Cancer in Icelandic Families, and Possible Relationship to Prostatic Cancer," Am. J. Hum. Genet. 52:711-717.
Bishop, T.D. and Gardner, E.J. (1980). "Analysis of the Genetic Predisposition to Cancer in Individual Pedigrees," Banbury Report 4: Cancer Incidence in Defined Populations, Cairns et al., eds., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp. 389-408.
Bishop, D.T., et al. (1988). "Segregation and Linkage Analysis of Nine Utah Breast Cancer Pedigrees," Genet. Epidemiol. 5:151-169.
Black, D.M., et al. (1993). "A Somatic Cell Hybrid Map of the Long Arm of Human Chromosome 17, Containing the Familial Breast Cancer Locus (BRCA1)," Am. J. Hum. Genet. 52:702-710.
Bowcock, A.M., et al. (1993). "THRA1 and D17S183 Flank an Interval of <4cM for the Breast-Ovarian Cancer Gene (BRCA1) on Chromosome 17q21," Am. J. Hum. Genet. 52: 718-722.
Boyd, J. (1995). "BRCA1: More than a hereditary breast cancer gene?" Nature Genetics 9:335-336.
Chamberlain, J.S., et al. (1993). "BRCA1 Maps Proximal to D17S579 on Chromosome 17q21 by Genetic Analysis," Am. J. Hum. Genet. 52:792-798.
Claus, E.B., et al. (1991). "Genetic Analysis of Breast Cancer in the Cancer and Steroid Hormone Study," Am. J. Hum. Genet. 48:232-242.
Cohen, B.B., et al. (1993). "Linkage of a Major Breast Cancer Gene to Chromosome 17q12-21: Results from 15 Edinburgh Families," Am. J. Hum. Genet. 52:723-729.
Devilee, P., et al. (1993). "Linkage to Markers for the Chromosome Region 17q12-q21 in 13 Dutch Breast Cancer Kindreds," Am. J. Hum. Genet. 52:730-735.
Dunphy, W.G. and Newport, J.W. (1989). "Fission Yeast p13 Blocks Mitotic Activation and Tyrosine Dephosphorylation of the Xenopus cdc2 Protein Kinase," Cell 58:181-191.
Easton, D.F., et al. (1993). "Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families," Am. J. Hum. Genet. 52:678-701.
Fain, P.R. (1992). "Third international workshop on human chromosome 17 mapping," Cytogen. Cell Genet. 60:178-186.
Feunteun, J., et al. (1993). "A Breast-Ovarian Cancer Susceptibility Gene Maps to Chromosome 17q21," Am. J. Hum. Genet. 52:736-742.
Ford, D., et al. (1993). "The risks of cancer in BRCA1 mutation carriers," Am. J. Hum. Genet. 53(supplement):abstract No. 298 (page # not applicable).
Futreal, P.A., et al. (1994). "BRCA1 Mutations in Primary Breast and Ovarian Carcinomas," Science 266:120-122.
Go, R.C.P., et al. (1983). "Genetic Epidemiology of Breast Cancer and Associated Cancers in High-Risk Families. I. Segregation Analysis," J. Natl. Cancer Inst. 71:455-461.
Goldgar, D.E., et al. (1993). "Chromosome 17q Linkage Studies of 18 Utah Breast Cancer Kindreds," Am. J. Hum. Genet. 52:743-748.
Gould, K.L. and Nurse, P. (1989). "Tyrosine phosphorylation of the fission yeast cdc2.sup.+ protein kinase regulates entry into mitosis," Nature 342:39-45.
Hall, J.M., et al. (1990). "Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21," Science 250:1684-1689.
Hall, J.M., et al. (1992). "Closing in on a Breast Cancer Gene on Chromosome 17q," Am. J. Hum. Genet. 50:1235-1241.
Hosking, L., et al. (1995). "A somatic BRCA1 mutation in an ovarian tumour," Nature Genetics 9:343-344.
Ishibashi, T., et al. (1992). "Expression cloning of a human dual-specificity phosphatase," Proc. Natl. Acad. Sci. USA 89:12170-12174.
Kamb, A., et al. (1994). "Localization of the VHR Phosphatase Gene and Its Analysis as a Candidate for BRCA1," Genomics 23:163-167.
Kumagai, A. and Dunphy, W.G. (1991). "The cdc25 Protein Controls Tyrosine Dephosphorylation of the cdc2 Protein in a Cell-Free System," Cell 64:903-914.
Lindblom, A., et al. (1993). "Linkage Analysis with Markers on 17q in 29 Swedish Breast Cancer Families," Am. J. Hum. Genet. 52:749-753.
Malkin, D., et al. (1990). "Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms," Science 250:1233-1238.
Margaritte, P., et al. (1992). "Linkage of Familial Breast Cancer to Chromosome 17q21 May Not be Restricted to Early-Onset Disease," Am. J. Hum. Genet. 50:1231-1234.
Mazoyer, S., et al. (1993). "Linkage Analysis of 19 French Breast Cancer Families, with Five Chromosome 17q Markers," Am. J. Hum. Genet. 52:754-760.
Merajver, S.D., et al. (1995). "Somatic mutations in the BRCA1 gene in sporadic ovarian tumours," Nature Genetices 9:439-443.
Miki, Y., et al. (1994). "A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1," Science 266:66-71.
Milner, B.J., et al. (1993). "Linkage Studies with 17q and 18q Markers in a Breast/Ovarian Cancer Family," Am. J. Hum. Genet. 52:761-766.
Narod, S.A., et al. (1991). "Familial breast-ovarian cancer locus on chromosome 17q12-q23," Lancet 338:82-83.
Newman, B. et al. (1988). "Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families," Proc. Natl. Acad. Sci. USA 85:3044-3048.
O'Connell, P., et al. (1994). "A Radiation Hybrid Map of the BRCA1 Region," Am. J. Hum. Genet. 54:526-534.
Roberts, L. (1993). "Zeroing In on a Breast Cancer Susceptibility Gene," Science 259:622-625.
Shattuck-Eidens, D., et al. (1995). "A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene," JAMA 273:535-541.
Simard, J., et al. (1994). "Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families," Nature Genetics 8:392-398.
Smith, S.A., et al. (1992). "Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome," Nature Genetics 2:128-131.
Smith, S.A., et al. (1993). "Genetic Heterogeneity and Localization of a Familial Breast-Ovarian Cancer Gene on Chromosome 17q12-q21," Am. J. Hum. Genet. 52:767-776.
Spurr, N.K., et al. (1993). "Linkage Analysis of Early-Onset Breast and Ovarian Cancer Families, with Markers on the Long Arm of Chromosome 17," Am. J. Hum. Genet. 52:777-785.
Teare, M.D., et al. (1993). "A Linkage Study in Seven Breast Cancer Families," Am. J. Hum. Genet. 52:786-788.
Thompson, M.E., et al. (1995). "Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression," Nature Genetics 9:444-450.
Ullrich, A. and Schlessinger, J. (1990). "Signal Transductin by Receptors with Tyrosine Kinase Activity," Cell 61:203-212.
Williams, W.R. and Anderson, D.E. (1984). "Genetic Epidemiology of Breast Cancer: Segregation Analysis of 200 Danish Pedigrees," Genet. Epidemiol. 1:7-20.
Zimmermann, W., et al. (1993). "Linkage Analysis in German Breast Cancer Fam
Futreal P. Andrew
Goldgar David E.
Harshman Keith D.
Kamb Alexander
Miki Yoshio
Jones W. Gary
Myriad Genetics Inc.
Rees Dianne
The United States of America as represented by the Secretary of
University of Utah Research Foundation
LandOfFree
17q-linked breast and ovarian cancer susceptibility gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 17q-linked breast and ovarian cancer susceptibility gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17q-linked breast and ovarian cancer susceptibility gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-724429